Population
Cultured neonatal rat cardiomyocytes and in vivo rat myocardial ischemia/reperfusion (IR) model
Comparison
Overexpression of CaMKII-deltaB vs Overexpression of CaMKII-deltaC or control
Design
Preclinical
Authors
Loading...
Isoform-selective CaMKII modulation may reduce cardiomyocyte apoptosis in ischemic settings; leaves open in vivo translation and clinical relevance.
CaMKII-deltaB acts as a potent suppressor of cardiomyocyte apoptosis via phosphorylation of HSF1 and induction of iHSP70, identifying it as a potential therapeutic target for ischemic heart disease.
Peng et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: